Clinical trials

  • GSK3862995B for Bronchiectasis
  • Lenvatinib for Locally advanced head and neck squamous cell carcinoma
  • Faricimab for Subretinal hyperreflective material | Age-related macular degeneration
  • clopidogrel for Atrial fibrillation
  • CLN-081 for Non-small cell lung cancer with EGFR exon 20 insertion mutations
  • ATACICEPT for IgA nephropathy
  • Letrozole for Low-grade serous carcinoma of the ovary | Low-grade serous carcinoma of the peritoneum
  • ATROPINE SULFATE for Myopia
  • BELATACEPT for Kidney transplantation | Subclinical antibody-mediated rejection | De novo donor-specific antibodies (dnDSA)
  • ORTICUMAB for Atherosclerotic cardiovascular disease | Myocardial infarction
  • PLITIDEPSIN for Post-COVID-19 Condition (PCC) | Post-COVID-19 syndrome
  • JNJ-89402638 for Metastatic colorectal cancer | Gastric cancer